Vanguard Personalized Indexing Management
GMED icon

Vanguard Personalized Indexing Management’s Globus Medical GMED Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
14,869
-2,209
-13% -$188K 0.01% 907
2026
Q1 		$1.47M Buy
17,078
+890
+5% +$79.9K 0.01% 746
2025
Q4 		$1.41M Buy
16,188
+2,554
+19% +$194K 0.01% 747
2025
Q3 		$781K Sell
13,634
-42
-0.3% -$2.42K 0.01% 1030
2025
Q2 		$807K Sell
13,676
-518
-4% -$33.5K 0.01% 971
2025
Q1 		$1.04M Buy
14,194
+750
+6% +$62K 0.02% 765
2024
Q4 		$1.11M Buy
13,444
+1,359
+11% +$107K 0.02% 728
2024
Q3 		$865K Buy
12,085
+421
+4% +$29.7K 0.01% 835
2024
Q2 		$798K Buy
11,664
+1,616
+16% +$96.5K 0.02% 786
2024
Q1 		$539K Sell
10,048
-4,745
-32% -$255K 0.01% 982
2023
Q4 		$788K Buy
14,793
+7,737
+110% +$377K 0.02% 771
2023
Q3 		$350K Buy
7,056
+2,821
+67% +$158K 0.01% 1057
2023
Q2 		$252K Buy
4,235
+295
+7% +$16.8K 0.01% 1222
2023
Q1 		$223K Sell
3,940
-5,204
-57% -$334K 0.01% 1275
2022
Q4 		$679K Buy
9,144
+1,752
+24% +$119K 0.03% 678
2022
Q3 		$440K Buy
7,392
+228
+3% +$13.7K 0.02% 831
2022
Q2 		$402K Sell
7,164
-3,385
-32% -$222K 0.02% 890
2022
Q1 		$778K Buy
+10,549
New +$733K 0.04% 603
2021
Q4 		– Sell
-4,266
Closed -$327K – 1078
2021
Q3 		$327K Sell
4,266
-2,097
-33% -$168K 0.03% 729
2021
Q2 		$493K Buy
+6,363
New +$452K 0.05% 484

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Personalized Indexing Management's GMED Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Globus Medical (GMED) stake by 13% in Q2 2026, selling an estimated $188K and leaving 14,869 shares worth $1.17M. The position accounts for 0.01% of the portfolio, ranked #907.

Vanguard Personalized Indexing Management first reported a position in GMED in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.47M in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Vanguard Personalized Indexing Management held 14,869 shares of Globus Medical worth $1.17M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 2,209 Globus Medical shares in Q2 2026, an estimated $188K.
  • Globus Medical made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #907 holding.
  • Vanguard Personalized Indexing Management first reported a position in Globus Medical in Q2 2021 and has held it in 20 quarters since.
  • Vanguard Personalized Indexing Management's Globus Medical position peaked at $1.47M in Q1 2026.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.